Virus Expression Database
Submitted by David Redmond (Weill Cornell Medicine, USA) on Jun 04 2020
Platform: ngs – Illumina NovaSeq 6000 (Homo sapiens)
Pubmed: None listed
Summary We systematically probed which cell types are permissive to SARS-CoV-2 infection. Transcriptomic analysis following SARS-CoV-2 infection of hPSC-derived pancreatic and lung organoids revealed upregulation of chemokines but not type I/III interferon signaling, similar to what was seen in primary human COVID-19 pulmonary infection.
| ID | Title | Cell Type | Timepoint | Reported Virus | Virus Species | Exclusion Reason |
|---|---|---|---|---|---|---|
| GSM4591144 | X45.1: Liver Organoid Donor 1 Mock 1 | liver  |
Mock | Uninfected | ||
| GSM4591145 | X45.2: Liver Organoid Donor 1 Mock 2 | liver |
Mock | Uninfected | ||
| GSM4591146 | X45.3: Liver Organoid Donor 1 SARS-CoV-2 1 | liver |
24 hrs | sars-Cov2 | Severe acute respiratory syndrome-related coronavirus | |
| GSM4591147 | X50.1: Liver Organoid Donor 1 Mock 1 R2 | liver |
Mock | Uninfected | ||
| GSM4591148 | X50.2: Liver Organoid Donor 1 Mock 2 R2 | liver |
Mock | Uninfected | ||
| GSM4591149 | X50.3: Liver Organoid Donor 1 SARS-CoV-2 1 R2 | liver |
24 hrs | sars-Cov2 | Severe acute respiratory syndrome-related coronavirus | |
| GSM4591150 | X50.4: Liver Organoid Donor 1 SARS-CoV-2 2 R2 | liver |
24 hrs | sars-Cov2 | Severe acute respiratory syndrome-related coronavirus | |
| GSM4591151 | X50.5: Liver Organoid Donor 2 Mock 1 R2 | liver |
Mock | Uninfected | ||
| GSM4591152 | X50.6: Liver Organoid Donor 2 Mock 2 R2 | liver |
Mock | Uninfected | ||
| GSM4591153 | X50.7: Liver Organoid Donor 2 SARS-CoV-2 1 R2 | liver |
24 hrs | sars-Cov2 | Severe acute respiratory syndrome-related coronavirus | |
| GSM4591154 | X50.8: Liver Organoid Donor 2 SARS-CoV-2 2 R2 | liver |
24 hrs | sars-Cov2 | Severe acute respiratory syndrome-related coronavirus | |
| GSM4591155 | X52.22: Liver Organoid Donor 1 SARS-CoV-2 2 | liver |
24 hrs | sars-Cov2 | Severe acute respiratory syndrome-related coronavirus | |
| GSM4591156 | L.2: COVID-19 Lung 51L | lung |
24 hrs | sars-Cov2 | Severe acute respiratory syndrome-related coronavirus | |
| GSM4591157 | L.3: COVID-19 Lung 56L | lung |
24 hrs | sars-Cov2 | Severe acute respiratory syndrome-related coronavirus | |
| GSM4591158 | L.4: COVID-19 Lung 58L | lung |
24 hrs | sars-Cov2 | Severe acute respiratory syndrome-related coronavirus | |
| GSM4591159 | hESC.Pancreas.SARSCoV2.1 | pancreatic cell line |
24 hrs | sars-Cov2 | Severe acute respiratory syndrome-related coronavirus | |
| GSM4591160 | hESC.Pancreas.SARSCoV2.2 | pancreatic cell line |
24 hrs | sars-Cov2 | Severe acute respiratory syndrome-related coronavirus | |
| GSM4591161 | hESC.Pancreas.SARSCoV2.3 | pancreatic cell line |
24 hrs | sars-Cov2 | Severe acute respiratory syndrome-related coronavirus | |
| GSM4591162 | hESC.Pancreas.mock.1 | pancreatic cell line |
Mock | Uninfected | ||
| GSM4591163 | hESC.Pancreas.mock.2 | pancreatic cell line |
Mock | Uninfected | ||
| GSM4591164 | hESC.Pancreas.mock.3 | pancreatic cell line |
Mock | Uninfected |